Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Luzsana Biotechnology
Pharma
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
Hengrui debuts global startup. Merck signs a potential $1.4 billion deal for a Chinese firm's cancer program. Dr. Reddy's sees growth in Russia.
Angus Liu
May 20, 2022 9:15am
'Startup like no other': Hengrui goes global with new unit
May 18, 2022 7:00am
